期刊信息查詢系統

期刊標題檢索 PITUITARY 最新評論: Before you start your research, you should conduct a comprehensive lit... (2021-12-30)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Pituitary]您好，您是該頁面的第 13242 位訪客。

期刊簡介

期刊名稱

Pituitary
LetPub Score

6.3

50 ratings

Rate

Reputation

7.5

Influence

5.1

Speed

7.0

期刊簡稱

PITUITARY

ISSN

1386-341X

E-ISSN

1573-7403

h-index

CiteScore

SJR

SNIP

CiteScore Rank

7.10

1.091

1.209

Subject field	Quartiles	Rank	Percentile
Category: Medicine Subcategory: Endocrinology, Diabetes and Metabolism	Q2	66 / 244
Category: Medicine Subcategory: Endocrinology	Q2	44 / 128

自引率 (2023-2024)

6.10%自引率趨勢

掲載範囲

Pituitary is an international publication devoted to basic and clinical aspects of the pituitary gland. It is designed to publish original, high quality research in both basic and pituitary function as well as clinical pituitary disease.

The journal considers:

Biology of Pituitary Tumors
Mechanisms of Pituitary Hormone Secretion
Regulation of Pituitary Function
Prospective Clinical Studies of Pituitary Disease
Critical Basic and Clinical Reviews

Pituitary is directed at basic investigators, physiologists, clinical adult and pediatric endocrinologists, neurosurgeons and reproductive endocrinologists interested in the broad field of the pituitary and its disorders. The Editorial Board has been drawn from international experts in basic and clinical endocrinology. The journal offers a rapid turnaround time for review of manuscripts, and the high standard of the journal is maintained by a selective peer-review process which aims to publish only the highest quality manuscripts. Pituitary will foster the publication of creative scholarship as it pertains to the pituitary and will provide a forum for basic scientists and clinicians to publish their high quality pituitary-related work.

官方網站

https://www.springer.com/11102

在線稿件提交

https://submission.nature.com/new-submission/11102/3

開放訪問

出版商

Springer US

主題領域

医学

出版國/地區

UNITED STATES

發行頻率

四半期刊行

創刊年

1998

每年文章數

72每年文章數趨勢

黃金OA百分比

31.73%

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q2

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
ENDOCRINOLOGY & METABOLISM	SCIE	Q2	77/186

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1386-341X%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: Average 6 Month(s)

競爭力 *

來自作者的數據: About 75%

參考鏈接

相關期刊	【Pituitary】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
Nature Reviews Endocrinology	H-index: 116 CiteScore: 42.00
Cell Metabolism	H-index: 219 CiteScore: 48.60
ENDOCRINE REVIEWS	H-index: 257 CiteScore: 42.00
DIABETES CARE	H-index: 328 CiteScore: 29.50
TRENDS IN ENDOCRINOLOGY AND METABOLISM	H-index: 146 CiteScore: 20.10
METABOLISM-CLINICAL AND EXPERIMENTAL	H-index: 122 CiteScore: 18.90
Cardiovascular Diabetology	H-index: 64 CiteScore: 12.30
DIABETOLOGIA	H-index: 207 CiteScore: 18.10
JOURNAL OF PINEAL RESEARCH	H-index: 113 CiteScore: 17.70
Obesity Reviews	H-index: 137 CiteScore: 19.30

學科內最受檢索的期刊	頁面查看次數
FREE RADICAL BIOLOGY AND MEDICINE	191874
Cell Metabolism	129877
DIABETES	101923
JOURNAL OF PINEAL RESEARCH	98779
BIOLOGICAL TRACE ELEMENT RESEARCH	92877
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM	81296
ANTIOXIDANTS & REDOX SIGNALING	79924
DIABETES CARE	73475
BONE	70441
Obesity	68350

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Pituitary] 的評論	撰寫評論

作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 23:06:51 評論於 Before you start your research, you should conduct a comprehensive literature search and read relevant review articles in the field (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 22:24:02 評論於 References should be as recent as possible, within the last 5 years. For original and foundational research findings, earlier papers can be cited (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 魂魄彦露領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 11:27:07 評論於 How to comprehensively include important research in the introduction? (0) 讚！ \| 魂魄彦露
作者: 深渊兴业領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-26 16:18:54 評論於 Can very old articles be cited in the introduction? (0) 讚！ \| 深渊兴业
作者: 孤云逸云領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2016-10-03 08:34:07 評論於 Review Speed: 1.0 Experience Sharing: The efficiency of the journal is very high. The first review took 8 days with 2 reviewers, and required major revisions. It took 21 days to revise the paper, and was accepted after the second review in 1 day. The entire process from submission to acceptance took 30 days. After acceptance, on the 6th day, there was a query about choosing Open Access and copyright transfer. The proof was sent on the 7th day, and the paper was published online on the 8th day (0) 讚！ \| 孤云逸云
作者: 风神沈思領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2016-09-23 20:52:58 評論於 30 days total reception Guo_Zai 2016-09-02 Posted: A major overhaul, under modification (0) 讚！ \| 风神沈思
作者: 风神沈思領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2016-09-02 14:09:36 評論於 One month major overhaul, currently under revision (0) 讚！ \| 风神沈思
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2013-07-01 12:31:33 評論於 This journal is now rated at 2.5, which is a significant increase from last year. Is there a chance to go a step further and reach 3 points? (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2013-07-01 09:42:58 評論於 We are 2 points ahead, will we be able to keep this lead next year, there is a lot of hope (0) 讚！ \| 凌霄高洁
作者: 正德可爱吗領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2012-01-06 14:50:02 評論於 Review speed: 6.0 \| Submission hit rate: 75.0 Experience sharing: It is relatively easy to submit papers in our research group (0) 讚！ \| 正德可爱吗

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [Pituitary] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 23:06:51 評論於 Before you start your research, you should conduct a comprehensive literature search and read relevant review articles in the field (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 22:24:02 評論於 References should be as recent as possible, within the last 5 years. For original and foundational research findings, earlier papers can be cited (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 魂魄彦露領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 11:27:07 評論於 How to comprehensively include important research in the introduction? (0) 讚！ \| 魂魄彦露
作者: 深渊兴业領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-26 16:18:54 評論於 Can very old articles be cited in the introduction? (0) 讚！ \| 深渊兴业
作者: 孤云逸云領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2016-10-03 08:34:07 評論於 Review Speed: 1.0 Experience Sharing: The efficiency of the journal is very high. The first review took 8 days with 2 reviewers, and required major revisions. It took 21 days to revise the paper, and was accepted after the second review in 1 day. The entire process from submission to acceptance took 30 days. After acceptance, on the 6th day, there was a query about choosing Open Access and copyright transfer. The proof was sent on the 7th day, and the paper was published online on the 8th day (0) 讚！ \| 孤云逸云
作者: 风神沈思領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2016-09-23 20:52:58 評論於 30 days total reception Guo_Zai 2016-09-02 Posted: A major overhaul, under modification (0) 讚！ \| 风神沈思
作者: 风神沈思領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2016-09-02 14:09:36 評論於 One month major overhaul, currently under revision (0) 讚！ \| 风神沈思
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2013-07-01 12:31:33 評論於 This journal is now rated at 2.5, which is a significant increase from last year. Is there a chance to go a step further and reach 3 points? (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2013-07-01 09:42:58 評論於 We are 2 points ahead, will we be able to keep this lead next year, there is a lot of hope (0) 讚！ \| 凌霄高洁
作者: 正德可爱吗領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2012-01-06 14:50:02 評論於 Review speed: 6.0 \| Submission hit rate: 75.0 Experience sharing: It is relatively easy to submit papers in our research group (0) 讚！ \| 正德可爱吗

首頁上一頁 1 下一頁末頁 (頁 /1)

Pituitary

期刊標題檢索 PITUITARY 最新評論: Before you start your research, you should conduct a comprehensive lit... (2021-12-30)

[Pituitary]您好，您是該頁面的第 13242 位訪客。

開始撰寫 [Pituitary] 的評論：

Contact us